Cyberattack takes its toll on RB's OTC brands

19 October 2017 - Deborah Wilkes

Archived

Sales at RB's Health division fell by 2% on a like-for-like basis in the third quarter of 2017, as the company experienced a "supply shortfall" associated with the cyberattack at the end of June 2017. The company said there had also been a "negative impact" from Scholl/Amopé footcare products.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: